Jereme M Sylvain Dexcom Inc (DXCM) insider trading activity

Jereme M Sylvain is EVP, Chief Financal Officer of DEXCOM INC. Currently has a direct ownership of 123,481 shares of DXCM, which is worth approximately $9.08 Million. The most recent transaction as insider was on Mar 12, 2025, when has been sold 12,001 shares (Common Stock) at a price of $70.38 per share, resulting in proceeds of $844,630. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K

54.29% 3M change

44.36% 12M change

Total Value Held $9.08 Million

Jereme M Sylvain Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2025	SELL Open market or private sale	$844,630 $70.38 p/Share	12,001 Reduced 8.86%	123,481 Common Stock
Mar 10 2025	SELL Open market or private sale	$517,929 $73.99 p/Share	7,000 Reduced 4.91%	135,482 Common Stock
Mar 08 2025	BUY Grant, award, or other acquisition	-	58,704 Added 29.18%	142,482 Common Stock
Jan 29 2025	SELL Open market or private sale	$181,641 $86.91 p/Share	2,090 Reduced 2.44%	83,526 Common Stock
Jan 28 2025	BUY Grant, award, or other acquisition	-	5,586 Added 6.12%	85,616 Common Stock
Dec 16 2024	SELL Open market or private sale	$57,191 $76.87 p/Share	744 Reduced 0.92%	80,030 Common Stock
Nov 15 2024	SELL Open market or private sale	$264,285 $75.51 p/Share	3,500 Reduced 4.15%	80,774 Common Stock
Sep 09 2024	SELL Open market or private sale	$51,585 $69.15 p/Share	746 Reduced 0.88%	84,274 Common Stock
Jun 10 2024	SELL Open market or private sale	$85,712 $115.05 p/Share	745 Reduced 0.87%	84,948 Common Stock
Mar 12 2024	SELL Open market or private sale	$1,567,355 $134.41 p/Share	11,661 Reduced 12.0%	85,534 Common Stock
Mar 08 2024	BUY Grant, award, or other acquisition	-	26,053 Added 21.14%	97,195 Common Stock
Feb 20 2024	SELL Open market or private sale	$392,562 $116.73 p/Share	3,363 Reduced 4.51%	71,142 Common Stock
Jan 16 2024	SELL Open market or private sale	$338,004 $123.63 p/Share	2,734 Reduced 3.54%	74,505 Common Stock
Jan 12 2024	BUY Grant, award, or other acquisition	-	7,171 Added 8.5%	77,239 Common Stock
Dec 18 2023	SELL Sale (or disposition) back to the issuer	$357,264 $121.85 p/Share	2,932 Reduced 4.02%	70,068 Common Stock
Aug 22 2023	SELL Open market or private sale	$192,476 $104.38 p/Share	1,844 Reduced 2.47%	72,867 Common Stock
May 22 2023	SELL Open market or private sale	$282,192 $117.58 p/Share	2,400 Reduced 3.11%	74,711 Common Stock
Mar 10 2023	SELL Sale (or disposition) back to the issuer	$1,071,445 $111.4 p/Share	9,618 Reduced 11.09%	77,111 Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	21,769 Added 20.06%	86,729 Common Stock
Feb 22 2023	SELL Open market or private sale	$274,896 $114.54 p/Share	2,400 Reduced 3.57%	64,837 Common Stock
Nov 21 2022	SELL Open market or private sale	$270,288 $112.62 p/Share	2,400 Reduced 3.45%	67,237 Common Stock
Jun 06 2022	SELL Open market or private sale	$180,942 $301.57 p/Share	600 Reduced 3.33%	17,408 Common Stock
Mar 09 2022	SELL Sale (or disposition) back to the issuer	$792,223 $406.06 p/Share	1,951 Reduced 9.78%	18,008 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	5,297 Added 20.97%	19,959 Common Stock
Mar 04 2022	SELL Open market or private sale	$253,764 $422.94 p/Share	600 Reduced 3.93%	14,662 Common Stock

JMS

Jereme M Sylvain

EVP, Chief Financal Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Value

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

Operation

Value

Type

News

Receive news related to DEXCOM INC

Track Activities on DXCM

Account